SITE Centers Corp. SC 13D/A Amendment Filed

Ticker: SITC · Form: SC 13D/A · Filed: Dec 2, 2024 · CIK: 894315

Sentiment: neutral

Topics: ownership-filing, sec-filing, amendment

Related Tickers: SITE

TL;DR

SITE Centers Corp. 13D/A amended, ownership update from Otto Alexander.

AI Summary

On November 27, 2024, SITE Centers Corp. filed an amendment (No. 28) to its Schedule 13D. This filing relates to the common shares of SITE Centers Corp. and was made by Otto Alexander, with mailing address at C/O KG CURA VERMOGENSVERWALTUNG G.M.B.H. in Hamburg, Germany. The filing concerns the ownership of securities under the Securities Exchange Act of 1934.

Why It Matters

This amendment to a Schedule 13D filing indicates a change or update in the beneficial ownership of SITE Centers Corp. by a significant holder, which could signal shifts in control or strategy.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant ownership stakes, which can lead to activist investor actions or changes in corporate control, introducing potential volatility.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this SC 13D/A filing?

This filing is an amendment (No. 28) to Schedule 13D, indicating an update regarding beneficial ownership of SITE Centers Corp. securities.

Who is the filing person in this amendment?

The filing person is Otto Alexander, with a mailing address at C/O KG CURA VERMOGENSVERWALTUNG G.M.B.H. in Hamburg, Germany.

What is the CUSIP number for SITE Centers Corp. common shares mentioned in the filing?

The CUSIP number for SITE Centers Corp. common shares is 251591103.

When was the event that required this filing to be made?

The date of the event which requires filing of this statement is November 27, 2024.

What is the company's IRS number as listed in the filing?

The IRS number for SITE Centers Corp. is 341723097.

Filing Stats: 1,470 words · 6 min read · ~5 pages · Grade level 5.7 · Accepted 2024-12-02 17:00:57

Key Financial Figures

Filing Documents

is hereby amended to add the following

Item 5 is hereby amended to add the following: (a) Alexander Otto may be deemed to beneficially own 2,647,984 Common Shares, representing 5.1% of the Issuers outstanding Common Shares (based on 52,430,161 Common Shares outstanding as of October 25, 2024 as reported by the Issuer in the Form 10-Q filed with the Securities and Exchange Commission on October 30, 2024). (b) With respect to any rights or powers to vote, or to direct the vote of, or to dispose of, or direct the disposition of, the Common Shares referenced in paragraph 5(a), Mr. Otto has sole voting power and sole dispositive power with regard to 2,647,984 Common Shares. (c) Other than as set forth below, the Reporting Person has not effected any transactions in the Common Shares in the last sixty days. Date Transaction Amount Price 11/07/2024 Sale 123,774 $ 15.94143 (1) 11/08/2024 Sale 82,165 $ 15.88398 (2) 11/11/2024 Sale 112,406 $ 16.19035 (3) 11/12/2024 Sale 189,324 $ 16.25254 (4) 11/13/2024 Sale 145,155 $ 15.91650 (5) 11/14/2024 Sale 46,598 $ 15.78016 (6) 11/15/2024 Sale 4,000 $ 15.80575 (7) 11/18/2024 Sale 3,742 $ 15.75213 (8) 11/19/2024 Sale 70,669 $ 16.04734 (9) 11/20/2024 Sale 76,709 $ 16.02932 (10) 11/21/2024 Sale 62,333 $ 16.18959 (11) 11/22/2024 Sale 71,420 $ 16.09723 (12) 11/25/2024 Sale 93,166 $ 16.00371 (13) 11/26/2024 Sale 77,786 $ 15.78249 (14) 11/27/2024 Sale 100,355 $ 15.77496 (15) 11/29/2024 Sale 59,083 $ 15.61685 (16) CUSIP No. 251591103 SCHEDULE 13D Page 4 of 6 Pages (1) Reflects the weighted average sale price. The range of prices for such transaction is between $15.83 and $16.165 (2) Reflects the weighted average sale price. The range of prices for such transaction is between $15.81 and $15.98 (3) Reflects the weighted average sale price. The range of prices for such transaction is between $15.86 and $16.29. (4)

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on Read The Filing